Legal & General Group’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.89M | Sell |
611,156
-3,274
| -0.5% | -$36.9K | ﹤0.01% | 1385 |
|
|
2025
Q1 | $6.2M | Buy |
614,430
+11,572
| +2% | +$117K | ﹤0.01% | 1416 |
|
|
2024
Q4 | $7.13M | Sell |
602,858
-2,730
| -0.5% | -$32.3K | ﹤0.01% | 1379 |
|
|
2024
Q3 | $6.99M | Buy |
605,588
+72,298
| +14% | +$834K | ﹤0.01% | 1393 |
|
|
2024
Q2 | $5.64M | Buy |
533,290
+98,950
| +23% | +$1.05M | ﹤0.01% | 1458 |
|
|
2024
Q1 | $4.58M | Buy |
434,340
+140,375
| +48% | +$1.48M | ﹤0.01% | 1565 |
|
|
2023
Q4 | $3.3M | Sell |
293,965
-1,158
| -0.4% | -$13K | ﹤0.01% | 1714 |
|
|
2023
Q3 | $3.45M | Sell |
295,123
-31,961
| -10% | -$373K | ﹤0.01% | 1643 |
|
|
2023
Q2 | $3.3M | Buy |
327,084
+210,001
| +179% | +$2.12M | ﹤0.01% | 1689 |
|
|
2023
Q1 | $864K | Buy |
117,083
+15,588
| +15% | +$115K | ﹤0.01% | 2185 |
|
|
2022
Q4 | $811K | Buy |
101,495
+3,578
| +4% | +$28.6K | ﹤0.01% | 2211 |
|
|
2022
Q3 | $315K | Buy |
+97,917
| New | +$315K | ﹤0.01% | 2465 |
|